Zafgen (Nasdaq:ZFGN) is a clinical-stage biopharmaceutical company developing potentially transformative therapies for patients affected by a range of metabolic diseases.
At the core of Zafgen are dedicated people whose resolve, compassion, collaborative mindset and enthusiasm for solving challenges is unwavering. We are driven by a sense of purpose to meet the unique needs of patients affected by a range of complex metabolic diseases who are depending on us to deliver first-in-class therapies that have the potential to significantly impact their lives.
In their own words, our team shares the Zafgen difference – what inspires them, what drives our work and their hopes for people impacted by the serious diseases we are determined to address.
